Evidence map›Paper›PMID 22134398›Full record

ArticleMolecules (Basel, Switzerland)2011

Protective effect of salidroside from Rhodiolae Radix on diabetes-induced oxidative stress in mice.

Fenglin Li, Hong Tang, Furen Xiao, Jingli Gong, Yong Peng, Xiangle Meng

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed.

  1. Article
  2. Review
  3. Exploring the Therapeutic Potential ofCurrent issues in molecular biology · 2025
    Article
  4. Article
  5. Article
  6. Phenolic Compounds ofInternational journal of molecular sciences · 2023
    Review
  7. Review
  8. Pharmaceutical biology · 2022
    Article
  9. Discovery of human pancreatic lipase inhibitors from root ofJournal of pharmaceutical analysis · 2022
    Article
  10. Article
  11. Phenolic Compounds fromMolecules (Basel, Switzerland) · 2021
    Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Rosenroot (Aging and disease · 2019
    Review
  18. Article
  19. Salidroside Protects Against Advanced Glycation End Products-Induced Vascular Endothelial Dysfunction.Medical science monitor : international medical journal of experimental and clinical research · 2018
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Fenglin LiKey Laboratory of Metastable Materials Science and Technology, College of Materials Science and Engineering, Yanshan University, Qinghuangdao 066004, China.
Hong Tang
Furen Xiao
Jingli Gong
Yong Peng
Xiangle Meng

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It has been confirmed that diabetes mellitus (DM) carries increased oxidative stress. This study evaluated the effects of salidroside from Rhodiolae Radix on diabetes-induced oxidative stress in mice. After induction of diabetes, diabetic mice were administered daily doses of 50, 100 and 200 mg/kg salidroside for 28 days. Body weights, fasting blood glucose (FBG), serum insulin, TC (total cholesterol), TG (triglyceride), malondialdehyde (MDA), superoxide dismutase (SOD), glutathione peroxidase (GPx) and catalase (CAT) were measured. Results showed that salidroside possessed hypoglycemic activity and protective effects against diabetes-induced oxidative stress, which could significantly reduce FBG, TC, TG and MDA levels, and at same time increase serum insulin levels, SOD, GPx and CAT activities. Therefore, salidroside should be considered as a candidate for future studies on diabetes.

Indexed as

AnimalsAntioxidantsBlood GlucoseBody WeightDiabetes Mellitus, ExperimentalFastingGlucosidesInsulinKidneyLipidsLiverMaleMalondialdehydeMiceOxidative StressPhenolsAntioxidantsBlood GlucoseGlucosidesInsulinLipidsMalondialdehydePhenolsProtective Agentsrhodioloside

Identifiers

PMID22134398
PMCPMC6264537

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.